Devyser Diagnostics AB (publ) (DVYSR.ST)

SEK 117.0

(0.0%)

Eps Summary of Devyser Diagnostics AB (publ)

Devyser Diagnostics AB (publ)'s latest annual eps in 2023 was -3.31 SEK , down -14.53% from previous year.
Devyser Diagnostics AB (publ)'s latest quarterly eps in 2024 Q1 was -0.75 SEK , up 6.25% from previous quarter.
Devyser Diagnostics AB (publ) reported an annual eps of -2.89 SEK in 2022, down -56.22% from previous year.
Devyser Diagnostics AB (publ) reported an annual eps of -1.85 SEK in 2021, up 99.51% from previous year.
Devyser Diagnostics AB (publ) reported a quarterly eps of -1.41 SEK for 2024 Q3, down -0.71% from previous quarter.
Devyser Diagnostics AB (publ) reported a quarterly eps of -0.75 SEK for 2024 Q1, up 6.25% from previous quarter.

Annual Eps Chart of Devyser Diagnostics AB (publ) (2023 - 2018)

Historical Annual Eps of Devyser Diagnostics AB (publ) (2023 - 2018)

Year	Eps	Eps Growth
2023	-3.31 SEK	-14.53%
2022	-2.89 SEK	-56.22%
2021	-1.85 SEK	99.51%
2020	-375.94 SEK	-255.66%
2019	241.52 SEK	1250.78%
2018	17.88 SEK	0.0%

Year	Eps	Eps Growth
2024 Q2	-1.40 SEK	-86.67%
2024 Q3	-1.41 SEK	-0.71%
2024 Q1	-0.75 SEK	6.25%
2023 FY	- SEK	-14.53%
2023 Q1	-1.23 SEK	-19.42%
2023 Q4	-0.80 SEK	-116.22%
2023 Q3	-0.37 SEK	58.89%
2023 Q2	-0.90 SEK	26.83%
2022 Q1	-0.39 SEK	58.06%
2022 FY	- SEK	-56.22%
2022 Q3	-0.55 SEK	38.89%
2022 Q4	-1.03 SEK	-87.27%
2022 Q2	-0.90 SEK	-130.77%
2021 Q4	-0.93 SEK	0.0%
2021 FY	- SEK	99.51%
2020 FY	- SEK	-255.66%
2019 FY	- SEK	1250.78%
2018 FY	- SEK	0.0%

Peer Eps Comparison of Devyser Diagnostics AB (publ)

Name	Eps	Eps Difference
AroCell AB (publ)	-0.26 SEK	-1173.077%
Immunovia AB (publ)	-7.38 SEK	55.149%
Prostatype Genomics AB (publ)	-0.24 SEK	-1279.167%
SenzaGen AB	-0.91 SEK	-263.736%
Spermosens AB	-0.15 SEK	-2106.667%